TLR2 expression is increased in rosacea and stimulates enhanced serine protease production by keratinocytes. - Wikidata - wikimedia - TriplyDB

TLR2 expression is increased in rosacea and stimulates enhanced serine protease production by keratinocytes.

TLR2 expression is increased in rosacea and stimulates enhanced serine protease production by keratinocytes.

http://www.wikidata.org/entity/Q34895507

about

The role of antimicrobial peptides in chronic inflammatory skin diseases Rosacea: The cytokine and chemokine network Rosacea: Molecular Mechanisms and Management of a Chronic Cutaneous Inflammatory Condition Skin barrier in rosacea Topical Ivermectin 10 mg/g and Oral Doxycycline 40 mg Modified-Release: Current Evidence on the Complementary Use of Anti-Inflammatory Rosacea Treatments Multidisciplinary Consideration of Potential Pathophysiologic Mechanisms of Paradoxical Erythema with Topical Brimonidine Therapy Papulopustular rosacea, skin immunity and Demodex: pityriasis folliculorum as a missing link Cathelicidin LL-37: an antimicrobial peptide with a role in inflammatory skin disease Acne and Rosacea.Recent advances in the understanding and management of rosacea.Regulation of the human cathelicidin antimicrobial peptide gene by 1α,25-dihydroxyvitamin D3 in primary immune cells Endothelial and axon reflex vasodilatation to acetylcholine in rosacea-affected skin.Rosacea: new and emerging treatments.Management of cutaneous rosacea: emphasis on new medical therapies.Skin microbiota: overview and role in the skin diseases acne vulgaris and rosacea.Structure and function of the human skin microbiome Microbial symbiosis with the innate immune defense system of the skin.Assessment of the genetic basis of rosacea by genome-wide association study Advances in understanding and managing rosacea: part 2: the central role, evaluation, and medical management of diffuse and persistent facial erythema of rosacea.Advances in understanding and managing rosacea: part 1: connecting the dots between pathophysiological mechanisms and common clinical features of rosacea with emphasis on vascular changes and facial erythema Light-emitting diodes downregulate cathelicidin, kallikrein and toll-like receptor 2 expressions in keratinocytes and rosacea-like mouse skin.Dermasence refining gel modulates pathogenetic factors of rosacea in vitro.Epithelial antimicrobial defence of the skin and intestine.Systemic isotretinoin therapy normalizes exaggerated TLR-2-mediated innate immune responses in acne patients Clinical, cellular, and molecular aspects in the pathophysiology of rosacea.Neurovascular and neuroimmune aspects in the pathophysiology of rosacea.The Parathyroid Hormone Second Receptor PTH2R and its Ligand Tuberoinfundibular Peptide of 39 Residues TIP39 Regulate Intracellular Calcium and Influence Keratinocyte Differentiation.Cathelicidin, kallikrein 5, and serine protease activity is inhibited during treatment of rosacea with azelaic acid 15% gel Kallikrein 5-mediated inflammation in rosacea: clinically relevant correlations with acute and chronic manifestations in rosacea and how individual treatments may provide therapeutic benefit An emerging treatment: Topical ivermectin for papulopustular rosacea.Antimicrobial peptides: old molecules with new ideas.Pattern recognition receptors in immune disorders affecting the skin.Why does allergic contact dermatitis exist?Innate immunity and the role of the antimicrobial peptide cathelicidin in inflammatory skin disease.Proteases and proteomics: cutting to the core of human skin pathologies.Immunology and pathogenesis of canine demodicosis.Rosacea - the ophthalmic perspective.Endoplasmic reticulum stress: key promoter of rosacea pathogenesis.Unleashing the therapeutic potential of human kallikrein-related serine proteases.Therapeutic targeting of Toll-like receptors in cutaneous disorders.

P2860

Q26764915-7923044A-E8D4-4C67-8C5A-935F2FEE129D Q27023344-B74901BC-DAEB-432B-A8FD-5B5F179BC11C Q28067747-782E3732-9C43-4CE2-A9C4-06EC8704F225 Q28069342-3E8A45E9-25AB-46D9-BCE2-D7C4E4FB90DC Q28072685-2E5C1D77-0AF9-47B6-9256-568E4FB85B7A Q28077384-DC01EAAF-514F-42BC-BE69-D6E5AF7F487D Q28250993-0299D297-7A45-4A44-AF50-B8E3B9B4CE3C Q28266421-0FFD016D-7936-4D5D-848A-949C0BAD5E24 Q30238647-3E4C9DA2-E5E8-45C0-BC0F-CE82387AAF44 Q33942083-E5C1DA43-2ADC-4A0A-BC64-EC2B6DCB42B7 Q34022785-308F8B02-8F61-489A-AFB5-66D43710121D Q34039070-7990D878-6351-4225-B799-8457E96B2D6D Q34434971-8560B35F-AC35-4536-8BD0-0DE7655D9497 Q34436744-5435098E-F0B6-483A-9F9D-C1B74B674AA3 Q34572012-88E0C439-B0EC-4A65-A755-B2D0AAE84E95 Q35044638-4608C684-1607-444D-94FB-BBF06EE49DB5 Q35216133-EF460444-79ED-4553-B155-6A63663E088F Q35614210-63D3BC4D-F1C9-48D2-AD2E-B3F117D9F833 Q35862102-39BC6C81-6FE0-4A3C-B2D4-6FF2C9E7194F Q35862114-3D08C456-71F5-45CD-A414-368C120CB1D2 Q36055641-FFB1590E-02BD-44E3-8752-E0BEEB4C56D2 Q36325038-6990BCE5-4593-414B-B19C-E2F3F2F9D3F6 Q36584725-D19564E6-A9EE-4E2A-AEF7-A7AEB7725885 Q36733948-CD3F1618-27DC-41DC-9EBF-BEA5711F35B4 Q36991412-C90AC4D3-4BFC-445C-835D-A822D063B1E6 Q36992055-021C29F3-368C-439C-BB62-A194CA2789BB Q37445297-43EFD603-4C46-4D02-AD46-EBAF3501044F Q37542502-CD0479CF-1302-42C3-A691-5400F868882E Q37595472-4048A11A-5C28-48D0-82F1-18E645B52849 Q37842875-29B5122F-F2D2-4AE2-8B39-619851513050 Q37967109-D98E42A3-F1EF-4D32-8793-8C6EB2BD8637 Q37991471-57DD9FDE-A73F-4FCD-838B-E49E75737639 Q38079271-DB6614CE-1B0C-458B-84F8-F1EFBBBBF0DA Q38184541-D0A117E8-CB68-492D-A696-49DB678B47F8 Q38200069-911C6F2E-EF5C-408C-8E4B-AF4E5BABACB9 Q38218646-2F9A0143-C32F-4B35-8846-7D0675892E8F Q38227612-ABBCB245-FFAE-4080-A85A-8CF4727A4B79 Q38232251-F1D50BFE-AE7A-4E14-930B-CAA706B79CB2 Q38362486-1FD11456-B9F2-49F9-8337-85CA235C191A Q38550117-09A66927-7ACF-4C77-9970-0D10AA1AFE94

P2860

TLR2 expression is increased in rosacea and stimulates enhanced serine protease production by keratinocytes.

http://www.wikidata.org/entity/Q34895507

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

TLR2 expression is increased i ...... e production by keratinocytes.

@ast

TLR2 expression is increased i ...... e production by keratinocytes.

@en

TLR2 expression is increased i ...... e production by keratinocytes.

@nl

type

label

TLR2 expression is increased i ...... e production by keratinocytes.

@ast

TLR2 expression is increased i ...... e production by keratinocytes.

@en

TLR2 expression is increased i ...... e production by keratinocytes.

@nl

prefLabel

TLR2 expression is increased i ...... e production by keratinocytes.

@ast

TLR2 expression is increased i ...... e production by keratinocytes.

@en

TLR2 expression is increased i ...... e production by keratinocytes.

@nl

P1433

Q34895507-91840171-F299-4FC9-822D-F4F030D080BE

P1476

Q34895507-AB7133F9-8C94-4B63-9A8B-88BE45FCDEF1

P2093

Q34895507-037FEF2F-23B1-4837-B207-0FBDAD90A15D

Q34895507-5DC839C4-A0E4-48A4-B86A-D2F44982CDF4

Q34895507-9B89076A-E17D-429E-9326-9E715EABF879

Q34895507-A9D64CAA-FC60-41D1-97E3-F13C4571523F

Q34895507-ADADF2C6-83BC-494E-B0EC-181445097607

Q34895507-E54BA602-49AC-4BDF-9266-20ED3E741EC9

P2860

Q34895507-09BBA1C6-4ECE-4245-99BA-BFCA041F24B4

Q34895507-2054039F-5A9D-4422-887E-0C5190E57917

Q34895507-21B6082B-14B3-48EA-A275-64DFFC25825A

Q34895507-3815805F-9907-4EA0-8FAD-7CB4DB341990

Q34895507-3BE3C678-4955-498F-93D8-9D51E933C57D

Q34895507-4715C997-12BD-4551-8336-4B7E29F7DF31

Q34895507-4B1B7E55-D88B-44B9-960B-CBD8F6714F52

Q34895507-56931847-C8D8-4698-93AC-028E9EF4E35A

Q34895507-59F3CA7C-AA0D-480D-BF89-D571B9984BD4

Q34895507-6077B4DF-A608-4486-8286-5A17CBA7DC77

P2888

Q34895507-C06954BF-AA0A-486C-8C09-A806F9C5EBCF

P304

Q34895507-471FB553-5130-468D-A526-03B17F477774

P31

Q34895507-F9BDC0B4-CCA1-45F9-A76A-59CA8A23B613

P356

Q34895507-C9C2601F-A947-42A5-9370-3E00797F6FBE

P407

Q34895507-6277123E-0DD9-4620-BE87-48636F2D33B8

P433

Q34895507-94B3015F-FC53-4708-ABB7-90C91A467C99

P478

Q34895507-37CC85AF-6982-42FD-A15C-F1565A614AD6

P50

Q34895507-10A883F0-CF38-4920-A947-FA89905B1D1E

Q34895507-75F6B838-A595-47D1-8085-63CF7361B9C9

P577

Q34895507-30BB8AB3-8AFC-4963-B007-F7B7285F6973

P5875

Q34895507-B1AE3540-94F7-4F3B-A83C-1E15BB38996F

P6179

Q34895507-CF0B3F28-CA27-4CE8-94BE-D29276594A22

P698

Q34895507-706CEC56-AC96-4733-A519-2A293C0DA8CD

P921

Q34895507-BD3F3ACA-7AFE-4788-AFD3-8B2DA3D6531D

P932

Q34895507-92DA7296-F102-4CE5-BB16-6DCAA13F8C52

P356

P1433

Journal of Investigative Dermatology

P1476

TLR2 expression is increased i ...... se production by keratinocytes

@en

P2093

Andrew W Borkowski

http://www.w3.org/2001/XMLSchema#string

Anna L Cogen

http://www.w3.org/2001/XMLSchema#string

Daniel T Macleod

http://www.w3.org/2001/XMLSchema#string

Kimberly Kanada

http://www.w3.org/2001/XMLSchema#string

Shin Morizane

http://www.w3.org/2001/XMLSchema#string

Teruaki Nakatsuji

http://www.w3.org/2001/XMLSchema#string

P2860

LEKTI is localized in lamellar granules, separated from KLK5 and KLK7, and is secreted in the extracellular spaces of the superficial stratum granulosum

Expression, subcellular localization and cytokinic modulation of Toll-like receptors (TLRs) in normal human keratinocytes: TLR2 up-regulation in psoriatic skin

Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin

Commensal bacteria regulate Toll-like receptor 3-dependent inflammation after skin injury

Antimicrobial property of lauric acid against Propionibacterium acnes: its therapeutic potential for inflammatory acne vulgaris

Topographical and temporal diversity of the human skin microbiome

Skin microbiota: a source of disease or defence?

Toll-like receptors

Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome

Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea

P2888

P304

688-697

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/JID.2010.351

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

131

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-11-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49635536

http://www.w3.org/2001/XMLSchema#string

P6179

1035430339

http://www.w3.org/2001/XMLSchema#string

P698

21107351

http://www.w3.org/2001/XMLSchema#string

P921

Toll-like receptor

P932

3085277

http://www.w3.org/2001/XMLSchema#string